Medication info

Acynar Neo Syrup (Amoxicillin Trihydrate · Clavulanate Potassium (14:1))

Prescription medicationSyrupOral
Ingredient · strength
Amoxicillin Hydrate›54.545g / 100gDilute Potassium Clavulanate›7.8g / 100g
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
A white or pale yellow powder to be dissolved before use as a syrup.
Packaging
50mL (11.0g) X 1 bottle
Approval status
Active

MFDS item code 201506544 · Notified 2015.09.15 · Insurance code 657805671

Summary

Main use
Treatment of recurrent or persistent acute otitis media and recurrent acute sinusitis in children
Who takes it
Adults · Children
Adult dose
○ Adults: There is no experience with the use of this drug in adults. ○ Patients with hepatic impairment: Use this drug with caution in patients with impaired liver function, and monitor liver function regularly. ○ To minimize the possibility of gastrointestinal upset, administer this drug at the beginning of a meal. Administration of this drug at the beginning of a meal increases the absorption of potassium clavulanate.
Child dose
○ Pediatric patients 3 months and older: The recommended dose of this drug, based on the amoxicillin content (600 mg/5 mL), is 90mg/kg/day in divided doses every 12 hours; administer for 10 days for acute otitis media and for 7 days for acute sinusitis. 8kg: Administer 3.0mL every 12 hours 12kg: Administer 4.5mL every 12 hours 16kg: Administer 6.0mL every 12 hours 20kg: Administer 7.5mL every 12 hours 24kg: Administer 9.0mL every 12 hours 28kg: Administer 10.5mL every 12 hours 32kg: Administer 12.0mL every 12 hours 36kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this drug in pediatric patients weighing 40kg or more.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of recurrent or persistent acute otitis media and recurrent acute sinusitis in children

  • Acute otitis media
  • acute sinusitis
View approved original text

This medication is effective against bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. It is specifically used to treat recurrent or persistent acute otitis media and recurrent acute sinusitis in children. It is suitable for children under 2 years old, those who have recently taken antibiotics for this condition within the last 3 months, or those attending daycare. This medication aids in the treatment of infections in children with these risk factors. Therefore, it effectively treats acute otitis media and acute sinusitis in children.

How to take

Adult dose

○ Adults: There is no experience with the use of this drug in adults. ○ Patients with hepatic impairment: Use this drug with caution in patients with impaired liver function, and monitor liver function regularly. ○ To minimize the possibility of gastrointestinal upset, administer this drug at the beginning of a meal. Administration of this drug at the beginning of a meal increases the absorption of potassium clavulanate.

Child dose

○ Pediatric patients 3 months and older: The recommended dose of this drug, based on the amoxicillin content (600 mg/5 mL), is 90mg/kg/day in divided doses every 12 hours; administer for 10 days for acute otitis media and for 7 days for acute sinusitis. 8kg: Administer 3.0mL every 12 hours 12kg: Administer 4.5mL every 12 hours 16kg: Administer 6.0mL every 12 hours 20kg: Administer 7.5mL every 12 hours 24kg: Administer 9.0mL every 12 hours 28kg: Administer 10.5mL every 12 hours 32kg: Administer 12.0mL every 12 hours 36kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this drug in pediatric patients weighing 40kg or more.

Precautions

This medication is a beta-lactam antibiotic and should not be administered to patients who have experienced hypersensitivity reactions to penicillins or cephalosporins. Special caution is warranted for patients with infectious mononucleosis or lymphocytic leukemia due to a higher risk of rash. Patients who have previously experienced hepatic dysfunction or jaundice from this medication or penicillin should not use it due to the risk of recurrence. This medication contains lactose and should not be given to patients with lactose intolerance or genetic metabolic disorders. Patients with impaired liver or kidney function should use this medication cautiously as it may accumulate in the body and enhance side effects. Allergic individuals or those with bronchial asthma should take special care due to the risk of hypersensitivity reactions. Patients receiving parenteral nutrition, the elderly, or patients in poor general condition may display symptoms of vitamin K deficiency, and should be closely monitored. Patients with gastrointestinal diseases or severe vomiting or diarrhea may experience impaired drug absorption. While this medication is generally well tolerated, side effects such as diarrhea, vomiting, rash, and contact dermatitis may occur, and treatment should be discontinued if symptoms are severe. Though rare, serious side effects such as liver dysfunction, severe skin reactions, blood abnormalities, and kidney damage have also been reported, necessitating immediate notification to healthcare personnel upon symptom occurrence. Hypersensitivity or anaphylaxis may occur, so patients should be observed sufficiently post-administration, prepared for emergencies. If diarrhea occurs during or after antibiotic use, consult healthcare personnel immediately, considering the possibility of pseudomembranous colitis. Caution is advised when using this medication for more than 14 days due to the risk of resistant bacteria and fungal infections. This medication is not effective against viral infections; it should only be used when a bacterial infection is confirmed and should be taken consistently during the prescribed duration. Avoid administration during the first trimester of pregnancy, and pregnant or nursing women should use it cautiously after consulting a physician. Its safety and efficacy have not been established in infants under 3 months old. Overdose may result in gastrointestinal symptoms, renal dysfunction, neurological abnormalities, etc., so notify healthcare personnel immediately upon any adverse symptoms. Before use, shake the medication well, and store it in the refrigerator after preparation, using it within 7 days. Keep it out of reach of children and store it away from direct sunlight and high temperatures.

Side effects

Contact dermatitis, diaper rash, diarrhea, vomiting, moniliasis, rash, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, anorexia, abdominal pain, abdominal bloating, constipation, colonic pain, acidemia, mucosal maculopapular rash, dry mouth, acute pancreatitis, candidiasis, antibiotic-associated colitis, elevated AST, elevated ALT, elevated ALP, elevated LDH, increased serum bilirubin, hepatitis, cholestatic jaundice, pruritus, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, vesicular exfoliative dermatitis, acute generalized exanthematous pustulosis, eosinophilia, drug reaction (DRESS), angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, bronchospasm, dyspnea, laryngeal edema, anaphylactic shock, reversible leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vaginal itching, vaginal burning, increased discharge, agitation, anxiety, behavioral changes, confusion, drowsiness, insomnia, hyperactivity, dizziness, headache, seizures, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, symptoms of vitamin K deficiency, symptoms of vitamin B deficiency, teeth staining, linear IgA disease, dysgeusia, malaise, dermatitis, oral edema, gastric pain, fluid and electrolyte imbalance, hyperactivity, drowsiness, interstitial kidney disease, oliguric renal failure, interstitial cerebral seizures, hypersensitivity shock, skin reactions, bleeding, pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It should be kept in a cool, dry place below 25 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

A white or pale yellow powder to be dissolved before use as a syrup.

Package unit

50mL (11.0g) X 1 bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.